Selected Media Appearances (4)
Many people with mild brain injuries don't get follow-up care
“It is well known that the US healthcare system is fractured, and that there is often poor coordination between acute and non-acute care,” said lead study author Seth Seabury, of the Keck School of Medicine at the University of Southern California in Los Angeles...
Most concussion patients get no care after leaving hospital
The lack of follow-up after a concussion is concerning because these patients can suffer adverse and debilitating effects for a very long time,” said Seth Seabury, a lead author of the study and director of the Keck-Schaeffer Initiative for Population Health Policy at the USC Schaeffer Center for Health Policy and Economics. “Even patients who reported experiencing significant post-concussive symptoms often failed to see a provider. This reflects a lack of awareness, among patients and providers, that their symptoms may be connected to their brain injury...
Minorities, Latino immigrants face the greatest risk of workplace injuries
We found that their risk was higher even when we accounted for education and other demographic characteristics,” said lead author Seth Seabury, director of the Keck-Schaeffer Initiative for Population Health at the USC Schaeffer Center for Health Policy and Economics and the Keck School of Medicine of USC. “Disparities in economic opportunities for minorities lead them to take more hazardous jobs that raise their risk of injury and disability...
Spending more on patients lowers doctors' malpractice risk, study finds
"More and more we are relying on physicians to help eliminate wasteful spending in health care. However, if physicians perceive that lowering spending will subject them to greater malpractice risk, it will be that much harder to move the needle on health care spending," said Seth Seabury, an author on the study from the USC Schaeffer Center for Health Policy and Economics...
Selected Articles (5)
William S Gange, Benjamin Xu, Seth A Seabury
2019 Patients age 50 or older with newly-diagnosed Type 2 diabetes (DM2) from 2007-2015 were recruited from the Optum Clinformatics Database. All patients were tracked for 6 years: 1 year prior to and 5 years after the index diabetes diagnosis. Diabetic patients (n= 30,752) were matched to individuals with no diabetes diagnosis (n= 27,134) by age, sex, and race. Outcome measures included the receipt of eye care and incidence of ophthalmic complications, including diabetic retinopathy (DR) and diabetic macular edema (DME).
Sarina Amin, Seth A Seabury, Narsing A Rao, Khristina Ipapo, Brian C Toy
2019 Medical claims and demographic data were obtained from OptumInsight Clinformatics Data Mart, a national company managing private sector healthcare plans with over 57 million beneficiaries. Inclusion required continuous enrollment for at least 15 months within 2007 to 2015 (n= 21,516,133). Inclusion in the uveitis/scleritis sample required an index uveitis/scleritis diagnosis from an eye care provider.
Brian C Toy, Youning Zhang, Sarina Amin, Narsing A Rao, Khristina Ipapo, Seth A Seabury
2019 Medical claims and demographic data were obtained from OptumInsight Clinformatics Data Mart, a large, national medical claims database. Inclusion required continuous enrollment for at least 15 months within 2007 to 2015 (n= 21,516,133). For inclusion in the uveitis sample, an eye care provider established the index uveitis diagnosis (index date). Patients with an index date within 3 months after incisional intraocular surgery were excluded (n= 137,536). For non-uveitis patients, an index date was randomly selected from the individual’s enrollment period.
Gary R Lichtenstein, Ahva Shahabi, Seth A Seabury, Darius N Lakdawalla, Oliver Díaz Espinosa, Sarah Green, Michelle Brauer, Robert N Baldassano
2019 We collected data from 78,620 patients with CD, 85,755 with UC, and propensity score-matched controls from the Truven Health MarketScan insurance claims databases (2008‒2015). Total medical (inpatient, outpatient) and pharmacy costs were captured. Cost variations over a lifetime were estimated in cost-state Markov models by age at diagnosis, adjusted to 2016 US dollars and discounted at 3% per annum. We measured lifetime total and lifetime incremental cost (the difference between costs of CD or UC patients vs matched controls).
Seth Seabury et al
2019 To characterize the natural history of recovery of daily function following mTBI vs peripheral orthopedic traumatic injury in the first 12 months postinjury using data from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study, and, using clinical computed tomographic (CT) scans, examine whether the presence (CT+) or absence (CT−) of acute intracranial findings in the mTBI group was associated with outcomes.
Seth Seabury, PhD, is an Associate Professor of Pharmaceutical and Health Economics in the School of Pharmacy and the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California.
Dr. Seabury's work examines the impact of health on productivity and how health care policy and law impact delivery of care and patient outcomes. His research has been published in leading journals in economics, medicine and health policy, including the American Economic Review, the New England Journal of Medicine and the Journal of the American Medical Association. It has also has been featured in major media outlets, including the New York Times, Washington Post and Wall Street Journal. His work on the impact of medical malpractice on physician behavior was used by the Congressional Budget Office to estimate the impact of tort reform on healthcare costs. He has testified to the US Congress about earnings losses experienced by permanently disabled workers, and he helped the State of California design and implement a new $150 million per year benefit program for injured workers. His research has been funded by the National Institutes for Health, the Institute of Medicine, the National Institute for Occupational Safety and Health, the California Department of Industrial Relations and the US Department of Labor.
Additionally, Dr. Seabury is a Faculty Research Fellow at the National Bureau of Economic Research. He has been a member of the National Academy of Social Insurance Workers' Compensation Data panel, served on the National Occupational Research Agenda Public Safety Council and co-authored reports for the National Academies of Sciences, Engineering, and Medicine. He is an associate editor of the International Review of Law and Economics. Prior to joining USC, Dr. Seabury was a Senior Economist at the RAND Corporation, where he was also the Associate Director of the Center for Health and Safety in the Workplace and a Professor of Economics at the Pardee RAND Graduate School.
Dr. Seabury received his Ph.D. in Economics from Columbia University and received his B.A. in Economics with Highest Honors from Kenyon College.
Areas of Expertise (5)
Value of Innovative Treatments
Pharmaceutical and Health Economics
Health Care Policy
Delivery of Care and Patient Outcomes
Medical Care Spending
AMCP Abstract Awards
ISPOR 18th Annual International Meeting Poster Presentation
Columbia University: Ph.D.
Kenyon College: B.A.
- Associate Editor, International Review of Law and Economics
- Standing Member, Agency for Healthcare Research and Quality, Healthcare Systems & Value Research Study Section
- Scientific Reviewer, NIOSH World Trade Center Cooperative Research Agreements